This Under-the-Radar Growth Stock Is Down 55%, but Wall Street Is Still Bullish. Here's Why.

Workiva reported first-half 2026 revenue of $502.6 million, up 19% year over year, and GAAP net income of $32.4 million versus a $40.7 million loss a year earlier; adjusted net income rose 416% to $99.6 million. Customers with annual contract values of at least $100,000 grew 20%, while those at $500,000 or more rose 33%, as the company adds AI agents to its compliance and reporting software. The stock was 55% below its 2021 high and traded at 4.2 times sales versus a five-year average of 7.6; analysts’ average $89.80 target implied 26% upside from $71, and management sees $2 billion in annualized revenue by 2030.

Analysis

The more important signal is mix, not headline customer growth: larger contract cohorts are expanding faster than the total base, consistent with land-and-expand economics and potentially greater revenue per customer. Verify that this is translating into durable subscription growth, retention, and cash collections; cohort counts alone do not establish net expansion or low churn.

AI is strategically relevant if it embeds Workiva deeper in auditable reporting workflows. That could raise switching costs, but also raises the bar for accuracy, permissions, and traceability: a material error in a filing could outweigh efficiency gains. In the medium term, AI features may defend renewals more readily than command a separate premium, while underinvestment in R&D to protect near-term margins could weaken product differentiation.

The valuation argument is less compelling than the article suggests. A discount to Workiva’s unusually elevated historical multiple is not, by itself, evidence of mispricing; the prior regime may not return. Broad analyst optimism also leaves less room for estimate upgrades. Near term, the next earnings update on large-customer growth, retention, bookings/RPO, and AI adoption is the key catalyst. Over 6–18 months, the thesis depends on sustained enterprise expansion without renewed expense growth or deterioration in product trust.

Key Decisions for Investors

• Consider a modest, staged long in WK rather than buying solely on the historical P/S comparison. Add only if the next report confirms continued growth in large-account cohorts alongside healthy retention and bookings; do not underwrite the case to analyst price targets.
• Treat AI as a catalyst to monitor, not yet a proven monetization driver. Look for disclosed adoption or attach rates and evidence that AI supports renewals or expansion; absent that, assume it is primarily a product-defense investment.
• Falsify the long thesis if large-customer growth materially decelerates, retention or bookings weaken, or management signals that cost restraint is impairing product investment. Reassess promptly if an AI-related reporting error damages customer confidence.
• Avoid a peer short or options trade on this evidence alone: the article provides no comparable retention, growth, or valuation data, and consensus optimism plus a lower multiple does not establish a near-term catalyst.